Autoantibodies in Sjogren's Syndrome

被引：134

作者：

Fayyaz, Anum ^{[1
,2
,3
]}

Kurien, Biji T. ^{[1
,2
,3
]}

Scofield, R. Hal ^{[1
,2
,3
]}

机构：

[1] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, 825 Northeast,13th St, Oklahoma City, OK 73104 USA

[2] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Coll Med, 1000 N Lincoln Blvd, Oklahoma City, OK 73104 USA

[3] US Dept Vet Affairs Hosp, Med & Res Serv, 921 NE 13th St, Oklahoma City, OK 73104 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2016年 / 42卷 / 03期

关键词：

Sjogren's syndrome; Autoantibodies; Congenital heart block; CONGENITAL HEART-BLOCK; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CITRULLINATED PEPTIDE ANTIBODIES; ALPHA-FODRIN ANTIBODIES; ANTICENTROMERE ANTIBODIES; NEONATAL LUPUS; CLINICAL-SIGNIFICANCE; RHEUMATOID-FACTOR; ANTI-RO/SSA; CLASSIFICATION CRITERIA;

D O I：

10.1016/j.rdc.2016.03.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We compiled information on antibodies in Sjogren syndrome (SS), focusing more on clinical manifestations associated with anti-Ro/SSA and anti-La/SSB antibodies and studies regarding novel antibodies. We reviewed previous as well as most recent studies with the subject heading Sjogren in combination with antibodies and congenital heart block (CHB). Almost half of asymptomatic mothers giving birth to children with CHB ultimately develop Sjogren. We discussed studies concerning the presence of antibodies predating clinical manifestations of disease. Studies in the future are required to ascertain the pathogenic mechanisms associated with these antibodies and the specific clinical manifestation related to new autoantibodies.

引用

页码：419 / +

页数：17

共 50 条

[31] Carbonic anhydrase autoantibodies and sicca symptoms in primary Sjogren's syndrome
Pertovaara, M.
Bootorabi, F.
Kuuslahti, M.
Uusitalo, H.
Pukander, J.
Helin, H.
Parkkila, S.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (03) : 456 - 457
[32] Analysis of novel Sjogren’s syndrome autoantibodies in patients with dry eyes
Sandra Everett
Sahana Vishwanath
Vanessa Cavero
Long Shen
Lakshmanan Suresh
Kishore Malyavantham
Norah Lincoff-Cohen
Julian L. Ambrus
BMC Ophthalmology, 17
[33] Autoantibodies and Sjogren's Syndrome in Multiple Sclerosis Compared to Neuromyelitis Optica
Solomon, Andrew J.
Hills, William
Whitham, Ruth
Rosenbaum, James T.
Bourdette, Dennis
NEUROLOGY, 2011, 76 (09) : A65 - A65
[34] The majority of patients with autoantibodies to GWBs have neuropathies and/or Sjogren's syndrome
Bhanji, Rahima A.
Eystathioy, Theophany
Chan, Edward K. L.
Fritzler, Marvin J.
JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1602 - 1602
[35] Autoantibodies and primary Sjogren's syndrome in a hypocitraturic stone population.
Eriksson, P
Denneberg, T
KIDNEY INTERNATIONAL, 1996, 49 (03) : 920 - 920
[36] Clinical features of Sjogren's syndrome patients with autoantibodies against interferons
Burbelo, Peter D.
Browne, Sarah
Holland, Steve M.
Iadarola, Michael J.
Alevizos, Ilias
CLINICAL AND TRANSLATIONAL MEDICINE, 2019, 8
[37] Autoantibodies against alpha-fodrin in patients with Sjogren's syndrome
Zeher, M
Csípo, I
Bacskó, G
Szántó, A
ADVANCES IN IMMUNOPATHOLOGY & RESPIRATORY ALLERGY, 2005, : 113 - 115
[38] Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes
Everett, Sandra
Vishwanath, Sahana
Cavero, Vanessa
Shen, Long
Suresh, Lakshmanan
Malyavantham, Kishore
Lincoff-Cohen, Norah
Ambrus, Julian L., Jr.
BMC OPHTHALMOLOGY, 2017, 17
[39] IgA and IgG autoantibodies against α-fodrin as markers for Sjogren's syndrome
Witte, T
Matthias, T
Arnett, FC
Peter, HH
Hartung, K
Sachse, C
Wigand, R
Braner, A
Kalden, JR
Lakomek, HJ
Schmidt, RE
JOURNAL OF RHEUMATOLOGY, 2000, 27 (11) : 2617 - 2620
[40] Clinical significance of autoantibodies recognizing Sjogren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjogren's syndrome
Goeb, V.
Salle, V.
Duhaut, P.
Jouen, F.
Smail, A.
Ducroix, J. -P.
Tron, F.
Le Loet, X.
Vittecoq, O.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 148 (02): : 281 - 287

← 1 2 3 4 5 →